References
- Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage – mechanisms and management approaches. N Engl J Med 2013;369:2021–30.
- Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr 2013;162:477–82 e1.
- Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) – Summary. Paediatr Child Health 2007;12:401–18.
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
- Lease M, Whalen B. Assessing jaundice in infants of 35-week gestation and greater. Curr Opin Pediatr 2010;22:352–65.
- Wainer S, Parmar SM, Allegro D, et al. Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia. Pediatrics 2012;129:77–86.
- Wickremasinghe AC, Karon BS, Saenger AK, et al. Effect of universal neonatal transcutaneous bilirubin screening on blood draws for bilirubin analysis and phototherapy usage. J Perinatol 2012;32:851–5.
- Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med 2003;31:81–8.
- Pratesi S, Boni L, Tofani L, et al. Comparison of the transcutaneous bilirubinometers BiliCare and Minolta JM-103 in late preterm and term neonates. J Matern Fetal Neonatal Med 2015. [Epub ahead of print]. DOI: 10.3109/14767058.2015.1113521.
- Taylor JA, Burgos AE, Flaherman V, et al. Discrepancies between transcutaneous and serum bilirubin measurements. Pediatrics 2015;135:224–31.
- Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol 2010;30:S6–15.
- Bosschaart N, Kok JH, Newsum AM, et al. Limitations and opportunities of transcutaneous bilirubin measurements. Pediatrics 2012;129:689–94.
- Sethi SK, Yadav D, Garg P, et al. A child with mental retardation and asymmetrical hypertrophy of limbs. Eur J Pediatr 2011;170:813–4.
- Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of > or = 35 weeks' gestation. Pediatrics 2006;117:1169–73.
- Rodriguez-Capote K, Kim K, Paes B, et al. Clinical implication of the difference between transcutaneous bilirubinometry and total serum bilirubin for the classification of newborns at risk of hyperbilirubinemia. Clin Biochem 2009;42:176–9.
- Panburana J, Boonkasidach S, Rearkyai S. Accuracy of transcutaneous bilirubinometry compare to total serum bilirubin measurement. J Med Assoc Thai 2010;93:S81–6.
- Sanpavat S, Nuchprayoon I. Noninvasive transcutaneous bilirubin as a screening test to identify the need for serum bilirubin assessment. J Med Assoc Thai 2004;87:1193–8.
- Bhutani VK, Gourley GR, Adler S, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:E17.
- Ho EY, Lee SY, Chow CB, et al. BiliCheck transcutaneous bilirubinometer: a screening tool for neonatal jaundice in the Chinese population. Hong Kong Med J 2006;12:99–102.
- Engle WD, Jackson GL, Stehel EK, et al. Evaluation of a transcutaneous jaundice meter following hospital discharge in term and near-term neonates. J Perinatol 2005;25:486–90.
- Kitsommart R, Pornladnun P, Chomchai C, et al. Accuracy and precision of transcutaneous bilirubinometry in postdischarge Asian neonates. Eur J Pediatr 2013;172:781–6.